Cancer Research AACR Membership  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Published online first on July 7, 2009
[Cancer Research, 10.1158/0008-5472.CAN-08-4623]
This Article
Right arrow Full Text (Online First [PDF])
Right arrow Supplementary Data
Right arrow All Versions of this Article:
0008-5472.CAN-08-4623v1
69/14/5918    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Bian, Y.
Right arrow Articles by Kulkarni, A. B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bian, Y.
Right arrow Articles by Kulkarni, A. B.

Molecular Biology, Pathobiology, and Genetics

Progressive Tumor Formation in Mice with Conditional Deletion of TGF-{beta} Signaling in Head and Neck Epithelia Is Associated with Activation of the PI3K/Akt Pathway

Yansong Bian 1, Anita Terse 1, Juan Du 1, Bradford Hall 1, Alfredo Molinolo 2, Pin Zhang 3, Wanjun Chen 3, Kathleen C. Flanders 4, J. Silvio Gutkind 2, Lalage M. Wakefield 4, and Ashok B. Kulkarni 1*

1Functional Genomics Section, Laboratory of Cell and Developmental Biology, 2Oral and Pharyngeal Cancer Branch, 3Mucosal Immunity Section, Oral Immunity and Infection Branch, National Institute of Dental and Craniofacial Research and 4Cancer Biology of TGF-{beta} Section, Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland

* To whom correspondence should be addressed. E-mail: ak40m{at}nih.gov.


   Abstract

The precise role of transforming growth factor (TGF)-{beta} signaling in head and neck squamous cell carcinoma (SCC) is not yet fully understood. Here, we report generation of an inducible head- and neck-specific knockout mouse model by crossing TGF-{beta} receptor I (Tgfbr1) floxed mice with K14-CreERtam mice. By applying tamoxifen to oral cavity of the mouse to induce Cre expression, we were able to conditionally delete Tgfbr1 in the mouse head and neck epithelia. On tumor induction with 7,12-dimethylbenz(a)anthracene (DMBA), 45% of Tgfbr1 conditional knockout (cKO) mice (n = 42) developed SCCs in the head and neck area starting from 16 weeks after treatment. However, no tumors were observed in the control littermates. A molecular analysis revealed an enhanced proliferation and loss of apoptosis in the basal layer of the head and neck epithelia of Tgfbr1 cKO mice 4 weeks after tamoxifen and DMBA treatment. The most notable finding of our study is that the phosphoinositide 3-kinase (PI3K)/Akt pathway was activated in SCCs that developed in the Tgfbr1 cKO mice on inactivation of TGF-{beta} signaling through Smad2/3 and DMBA treatment. These observations suggest that activation of Smad-independent pathways may contribute cooperatively with inactivation of Smad-dependent pathways to promote head and neck carcinogenesis in these mice. Our results revealed the critical role of the TGF-{beta} signaling pathway and its cross-talk with the PI3K/Akt pathway in suppressing head and neck carcinogenesis. [Cancer Res 2009;69(14):5918–26]

Key Words: TGF-{beta}, PI3K/Akt, Head and Neck Squamous Cell Carcinoma (HNSCC), Conditional Knockout, Cancer Mouse Model







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.